- Home
- COOK vs CMPX Comparison
COOK vs CMPX Comparison
Compare COOK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- CMPX
- Stock Information
- Founded
- COOK 1985
- CMPX 2014
- Country
- COOK United States
- CMPX United States
- Employees
- COOK N/A
- CMPX N/A
- Industry
- COOK Wholesale Distributors
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- CMPX Health Care
- Exchange
- COOK Nasdaq
- CMPX Nasdaq
- Market Cap
- COOK 255.1M
- CMPX 291.8M
- IPO Year
- COOK 2021
- CMPX N/A
- Fundamental
- Price
- COOK $1.90
- CMPX $2.99
- Analyst Decision
- COOK Buy
- CMPX Strong Buy
- Analyst Count
- COOK 7
- CMPX 9
- Target Price
- COOK $2.43
- CMPX $12.67
- AVG Volume (30 Days)
- COOK 287.3K
- CMPX 872.7K
- Earning Date
- COOK 08-05-2025
- CMPX 08-11-2025
- Dividend Yield
- COOK N/A
- CMPX N/A
- EPS Growth
- COOK N/A
- CMPX N/A
- EPS
- COOK N/A
- CMPX N/A
- Revenue
- COOK $602,441,000.00
- CMPX $850,000.00
- Revenue This Year
- COOK $0.06
- CMPX N/A
- Revenue Next Year
- COOK $3.18
- CMPX N/A
- P/E Ratio
- COOK N/A
- CMPX N/A
- Revenue Growth
- COOK 0.80
- CMPX N/A
- 52 Week Low
- COOK $1.28
- CMPX $0.87
- 52 Week High
- COOK $3.97
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- COOK 59.14
- CMPX 70.40
- Support Level
- COOK $1.91
- CMPX $2.64
- Resistance Level
- COOK $2.08
- CMPX $3.27
- Average True Range (ATR)
- COOK 0.11
- CMPX 0.18
- MACD
- COOK -0.00
- CMPX 0.04
- Stochastic Oscillator
- COOK 70.73
- CMPX 81.82
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.